Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Anglo-French Drugs & Industries unveils respiratory care products

Ruchika Sharma22 Oct 2022 5:00 PM IST

The range that the company launched has already received approval from Drug Control Department.

Gambia orders recall of several more suspected medicines after death of 70 children

Ruchika Sharma22 Oct 2022 3:00 PM IST

Banjul: Gambia on Friday ordered a recall of several more drugs suspected of causing the deaths of 70 children from acute renal failure, the health...

SEC Approves Serums Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal Vaccine

Serum Institute will start HPV vaccine supply to Indian govt in early 2023, says Adar Poonawalla

Ruchika Sharma22 Oct 2022 1:00 PM IST

"We are just one year later than what I'd have wanted to be in terms of our capacity," Poonawalla said.

Granules India Anakapally facility gets EU GMP certificate

Granules India net profit up 80 percent at Rs 145 crore in Q2

Ruchika Sharma22 Oct 2022 11:29 AM IST

Bengaluru: Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of the painkiller...

Glenmark Pharma unveils Teneligliptin plus Dapagliflozin FDC for type 2 diabetes

Ruchika Sharma22 Oct 2022 11:00 AM IST

Glenmark’s Zita D is priced at around Rs 14 per tablet for FDC of Teneligliptin 20mg + Dapagliflozin 5mg, and Rs 15 per tablet for FDC of...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis allows generic Leukemia drug production in 7 nations: Bloomberg

Ruchika Sharma21 Oct 2022 2:35 PM IST

Chronic myeloid leukemia is a cancer that starts in the blood-forming cells found in bone marrow, before spilling into the general blood stream.

Rajasthan Health Dept debunks cough syrup death rumours

Indonesia finds medicinal syrups with ingredients linked to fatal child kidney injury in children

Ruchika Sharma21 Oct 2022 1:30 PM IST

Ethylene glycol and diethylene glycol were detected in syrups found at the homes of some patients, health minister Budi Gunadi Sadikin said on...

Serum Institute stopped Covishield production in Dec 2021, says Poonawalla; claims there are no takers for booster shots as people are fed up

Ruchika Sharma21 Oct 2022 12:30 PM IST

Pune: Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of...

DNB Dermatology, Venereology and Leprosy in India: Check out NBE released Curriculum

Ruchika Sharma21 Oct 2022 11:45 AM IST

The National Board of Examinations (NBE) has released the Curriculum for DNB Dermatology, Venereology and Leprosy. Following are the...

Lupin, Natco Launch Bosentan Tablets in US With 180-Day Exclusivity

Lupin unveils Paliperidone ER Tablets in US

Ruchika Sharma21 Oct 2022 11:26 AM IST

Schizophrenia is frequently associated with significant distress and impairment in personal, family, social, educational, occupational, and other...

Fennec Pharma launches PEDMARK in US

Ruchika Sharma21 Oct 2022 10:00 AM IST

Research Triangle Park: Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, has announced the U.S. commercial...

USFDA grants emergency use nod for Novavax COVID vaccine,Adjuvanted as booster for adults

Ruchika Sharma20 Oct 2022 5:46 PM IST

Gaithersburg: Novavax, Inc. has announced that the company's COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok